You are here

Pharmala Biotech Holdings Inc.

Pharmala Biotech Holdings Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
MDMA
CSE Index: 
Currency: 

Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of the Substituted methylenedioxy- phenethylamines class (“MDXX”), including 3,4-Methylenedioxymethamphetamine (“MDMA”). Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug delivery pathways for these molecules.

You are here

Pharmala Biotech Holdings Inc. (MDMA)

SEDAR Information

Company Info

Address
82 Richmond St.
Toronto, ON M5C 1P1
Canada
Phone
1-855-444-6362
Email
outreach@pharmala.ca
Website
https://pharmala.ca/
Listing date
Tuesday, January 11, 2022
Transfer Agent
Marrelli Trust Company Limited
Email
investors@pharmala.ca
Auditor
Clearhouse LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
82,998,600
Reserved for Issuance: 
14,026,952

Company Officers

Nicholas Kadysh , President, Chief Executive Officer and Director
Carmelo Marrelli , Chief Financial Officer and Corporate Secretary
Shane Morris , Chief Operating Officer

News Releases

Bulletins

10/01/2022

2022-0110 - New Listing - Pharmala Biotech Holdings Inc. (MDMA)

le 10 janvier/January 2022

The common shares of Pharmala Biotech Holdings Inc.  have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-09-28-MJ-Unpacked_Website.jpg

MJUnpacked

Wednesday, September 28, 2022 to Friday, September 30, 2022
2022-10-03-Xplor-Mining-Convention-2022_Website.png

Xplor 2022 - Mining Convention

Monday, October 3, 2022 - 9:00am to Thursday, October 6, 2022 - 7:30pm